These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28669329)

  • 21. Efficacy and safety of a generic rosuvastatin in a real-world setting: prospective, observational clinical study in Lebanese patients.
    Betto M; Fares J; Saliba N; Ballout H
    Ann Saudi Med; 2017; 37(5):366-374. PubMed ID: 28988251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aortic blood pressure and arterial stiffness in patients with controlled resistant and non-resistant hypertension.
    Cai A; Siddiqui M; Judd EK; Oparil S; Calhoun DA
    J Clin Hypertens (Greenwich); 2020 Feb; 22(2):167-173. PubMed ID: 32049430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Jaruvongvanich V; Chenbhanich J; Sanguankeo A; Rattanawong P; Wijarnpreecha K; Upala S
    Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):e28-e35. PubMed ID: 28542113
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosuvastatin as a potential preventive drug for the development of hepatocellular carcinoma associated with non-alcoholic fatty liver disease in mice.
    Yokohama K; Fukunishi S; Ii M; Nakamura K; Ohama H; Tsuchimoto Y; Asai A; Tsuda Y; Higuchi K
    Int J Mol Med; 2016 Nov; 38(5):1499-1506. PubMed ID: 28025996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Eslami L; Merat S; Malekzadeh R; Nasseri-Moghaddam S; Aramin H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008623. PubMed ID: 24374462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial.
    Tam LS; Li EK; Shang Q; Tomlinson B; Lee VW; Lee KK; Li M; Kuan WP; Li TK; Tseung L; Yip GW; Freedman B; Yu CM
    Scand J Rheumatol; 2011 Nov; 40(6):411-21. PubMed ID: 21867445
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advanced fibrosis associates with atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Chen Y; Xu M; Wang T; Sun J; Sun W; Xu B; Huang X; Xu Y; Lu J; Li X; Wang W; Bi Y; Ning G
    Atherosclerosis; 2015 Jul; 241(1):145-50. PubMed ID: 25988358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
    Yusuf S; Lonn E; Pais P; Bosch J; López-Jaramillo P; Zhu J; Xavier D; Avezum A; Leiter LA; Piegas LS; Parkhomenko A; Keltai M; Keltai K; Sliwa K; Chazova I; Peters RJ; Held C; Yusoff K; Lewis BS; Jansky P; Khunti K; Toff WD; Reid CM; Varigos J; Accini JL; McKelvie R; Pogue J; Jung H; Liu L; Diaz R; Dans A; Dagenais G;
    N Engl J Med; 2016 May; 374(21):2032-43. PubMed ID: 27039945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAFLD and Increased Aortic Stiffness: Parallel or Common Physiopathological Mechanisms?
    Villela-Nogueira CA; Leite NC; Cardoso CR; Salles GF
    Int J Mol Sci; 2016 Apr; 17(4):. PubMed ID: 27104526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study.
    Long MT; Wang N; Larson MG; Mitchell GF; Palmisano J; Vasan RS; Hoffmann U; Speliotes EK; Vita JA; Benjamin EJ; Fox CS; Hamburg NM
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1284-91. PubMed ID: 25745056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
    Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of antihypertensive agents on arterial stiffness as evaluated by pulse wave velocity: clinical implications.
    Asmar R
    Am J Cardiovasc Drugs; 2001; 1(5):387-97. PubMed ID: 14728020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between non-alcoholic fatty liver with metabolic risk factors and brachial-ankle pulse wave velocity.
    Zhu WH; Fang LZ; Lu CR; Dai HL; Chen JH; Qiao QH; Chen LY
    World J Gastroenterol; 2015 Sep; 21(35):10192-9. PubMed ID: 26401084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aortic Stiffness, Ambulatory Blood Pressure, and Predictors of Response to Antihypertensive Therapy in Hemodialysis.
    Georgianos PI; Agarwal R
    Am J Kidney Dis; 2015 Aug; 66(2):305-12. PubMed ID: 25818679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of changing of conventional antihypertensive therapy to a triple fixed combination therapy with rosuvastatin in high cardiovascular risk patients].
    Ageev FT; Blankova ZN; Samsonova NS
    Kardiologiia; 2018 SMar; (S3):46-54. PubMed ID: 29782289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome.
    Ghiadoni L; Bruno RM; Cartoni G; Stea F; Magagna A; Virdis A; Grassi D; Ferri C; Taddei S
    Vascul Pharmacol; 2017 May; 92():16-21. PubMed ID: 26070528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Arterial Stiffness in Patients With Resistant Hypertension: Additional Insights Into the Pathophysiology of This Condition?
    Alsharari R; Lip GYH; Shantsila A
    Am J Hypertens; 2020 Feb; 33(2):107-115. PubMed ID: 31608357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statins: An Under-Appreciated Asset for the Prevention and the Treatment of NAFLD or NASH and the Related Cardiovascular Risk.
    Athyros VG; Boutari C; Stavropoulos K; Anagnostis P; Imprialos KP; Doumas M; Karagiannis A
    Curr Vasc Pharmacol; 2018; 16(3):246-253. PubMed ID: 28676019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril Study.
    Jekell A; Kahan T
    Blood Press; 2018 Apr; 27(2):88-98. PubMed ID: 29073803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing aortic stiffness is predictive of advanced liver fibrosis in patients with type 2 diabetes: the Rio-T2DM cohort study.
    Leite NC; Villela-Nogueira CA; Ferreira MT; Cardoso CR; Salles GF
    Liver Int; 2016 Jul; 36(7):977-85. PubMed ID: 26509555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.